Evidence map›Paper›PMID 25477749›Full record

ReviewContemporary oncology (Poznan, Poland)2014

The mystery of let-7d - a small RNA with great power.

Tomasz Kolenda, Weronika Przybyła, Anna Teresiak, Andrzej Mackiewicz, Katarzyna M Lamperska

Open access · goldAbstract readReview
In one paragraph

Review in Contemporary oncology (Poznan, Poland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Oncology reviews · 2020
    Article
  17. Article
  18. MiR-let-7d-3p regulates IL-17 expression through targeting AKT1/mTOR signaling in CD4In vitro cellular & developmental biology. Animal · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tomasz KolendaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland ; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Poland.
Weronika PrzybyłaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.
Anna TeresiakLaboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.
Andrzej MackiewiczDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland ; Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland.
Katarzyna M LamperskaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.
Greater Poland Cancer Center · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs belong to a class of small non-coding RNAs which can modulate gene expression. Disturbances in their expression and function may cause cancer formation, progression and cell response to various types of stress. The let-7 family is one of the most studied groups of miRNAs. The family contains 13 members with similar sequences and a wide spectrum of target genes. In this paper, we mostly focus on one member of the family - let-7d. This miRNA is dysregulated in many types of cancers. It can be over- or down-expressed, and it acts as a tumor suppressor or oncogene. It regulates various genes such as LIN28, C-MYC, K-RAS, HMGA2 and IMP-1. Moreover, let-7d has a significant impact on epithelial-to-mesenchymal transition (EMT) and formation of cancer initiating cells which are resistant to irradiation and chemical exposure and responsible for cancer metastasis. Let-7d can serve as a prognostic and predictive marker for personalization of the treatment. Let-7d is a small RNA with great power, but in different cell genetic backgrounds it acts in different ways, which makes this molecule still mysterious.

Indexed as

cancerchemotherapygene regulationlet-7dlet-7 familymiRNAradiotherapy

Identifiers

PMID25477749
PMCPMC4248056
OpenAlexW2087766388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.